Sign in

CIK 0001422142

  • Non-accelerated filer
  • Smaller reporting company

Whitehawk Therapeutics, Inc.

Sign in to watch
Ticker
WHWK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
611547850
Phone
+1 551-321-2234
Business address
2 HEADQUARTERS PLAZA, EAST BUILDING, 11TH FLOOR, MORRISTOWN, NJ, 07960
Former names
Aadi Bioscience, Inc., Aerpio Pharmaceuticals, Inc., ZETA ACQUISITION CORP II
  1. 3 Insider Initial Statement of Ownership
  2. 4 Derivatives Options or other derivatives
  3. 3 Insider Initial Statement of Ownership
  4. 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 9,689 shares at $1.94 ($18,797)
  5. 4 Open-market sale EXECUTIVE CHAIRMAN sold 40,000 shares at $1.71 ($68,316)
  6. 4 Open-market sale EXECUTIVE CHAIRMAN sold 40,000 shares at an average $1.43 ($57,354)
  7. 4 Open-market sale EXECUTIVE CHAIRMAN sold 40,000 shares at an average $1.43 ($57,217)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Open-market sale EXECUTIVE CHAIRMAN sold 40,000 shares at an average $1.79 ($71,511)
  16. 4 Open-market sale EXECUTIVE CHAIRMAN sold 40,000 shares at $1.93 ($77,184)
  17. 3 Insider Initial Statement of Ownership
  18. 4 Open-market sale EXECUTIVE CHAIRMAN sold 40,000 shares at an average $2.27 ($90,614)
  19. 4 Open-market sale EXECUTIVE CHAIRMAN sold 42,000 shares at an average $2.02 ($84,641)
  20. 4 Derivatives Options or other derivatives

Page 4 of 14 · 263 filings